NFAT: A Protein Involved in T-cell Development and Regulation

Target Name: Nuclear factor of activated T-cells

NCBI ID: P11317

Nuclear factor of activated T-cells

Other Name(s): NFAT

NFAT: A Protein Involved in T-cell Development and Regulation

Nuclear factor of activated T-cells (NFAT) is a protein that plays a crucial role in the development and regulation of T-cells, which are a vital part of the immune system. T-cells are a type of white blood cell that are responsible for fighting off infections and diseases caused by pathogens. They are produced in the bone marrow and are a vital part of the immune system, as they help to identify and destroy foreign particles that enter the body.

NFAT is a protein that is expressed in T-cells and is involved in the development and regulation of these cells. It is a non-coding RNA molecule that contains several unique domains, including a nuclear localization domain, a T-cell activation domain, and a C-terminal domain that contains a nuclear export signal.

One of the unique features of NFAT is its ability to induce the expression of several important genes that are involved in the development and regulation of T-cells. For example, NFAT has been shown to induce the expression of genes that are involved in the development and differentiation of T-cells, as well as genes that are involved in cell signaling and inflammation.

NFAT has also been shown to play a role in regulating the activity of T-cells. For example, it has been shown to inhibit the activity of the T-cell receptor (TCR), which is a protein that is involved in the recognition of foreign particles in the body. This suggests that NFAT may be a drug target (or biomarker) that can be used to treat T-cell-related diseases.

Another potential role of NFAT is its ability to modulate the expression of genes involved in cell signaling pathways. For example, NFAT has been shown to play a role in regulating the activity of the protein kinase A (PKA), which is involved in cell signaling. This suggests that NFAT may be a drug target (or biomarker) that can be used to treat a variety of diseases that are caused by the disruption of normal signaling pathways in T-cells.

NFAT has also been shown to play a role in the regulation of cellular processes that are important for the survival and growth of T-cells. For example, it has been shown to play a role in the regulation of the apoptosis (programmed cell death) process, which is a natural mechanism that helps to remove damaged or dysfunctional cells from the body. This suggests that NFAT may be a drug target (or biomarker) that can be used to treat a variety of diseases that are caused by the disruption of normal cellular processes.

In conclusion, NFAT is a protein that is involved in the development and regulation of T-cells. It is a non-coding RNA molecule that contains several unique domains, including a nuclear localization domain, a T-cell activation domain, and a C-terminal domain that contains a nuclear export signal. NFAT has been shown to induce the expression of genes that are involved in the development and differentiation of T-cells, as well as genes that are involved in cell signaling and inflammation. It has also been shown to play a role in regulating the activity of T-cells and in the regulation of cellular processes that are important for the survival and growth of T-cells. These properties make NFAT a potential drug target (or biomarker) that can be used to treat a variety of T-cell-related diseases.

Protein Name: Nuclear Factor Of Activated T-cells (nonspecified Subtype)

The "Nuclear factor of activated T-cells Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about Nuclear factor of activated T-cells comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets